CAR-T Cancer Approach Has Surprising Success in Multiple Myeloma

Sodium Intake And Its Association With Multiple Sclerosis Progression
June 30, 2017
‘Miracle’ hepatitis C drugs costing £30k per patient ‘may have no clinical effect’ 
July 3, 2017
Show all

CAR-T Cancer Approach Has Surprising Success in Multiple Myeloma

Multiple myeloma might be treated with a new cell and gene therapy.

Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level of remission within two months.

In a second study of nearly two dozen patients, everyone above a certain dose responded.

Experts at an American Society of Clinical Oncology conference in Chicago, where the results were announced Monday, say it’s a first for multiple myeloma and rare for any cancer treatment to have such success.

Chemotherapy helps 10 to 30 percent of patients; immune system drugs, 35 to 40 percent at best, and some gene-targeting drugs, 70 to 80 percent, “but you don’t get to 100,” said Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society.

Read full article: CAR-T Cancer Approach Has Surprising Success in Multiple Myeloma – NBC News

Read Full Article: CAR-T Cancer Approach Has Surprising Success in Multiple Myeloma – NBC News

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.